Confirmation of High Safety and Efficacy of Artificial Protein Silk-Elastin® in Chronic Wound Healing－Innovative Material for Chronic Wound Healing Moves Toward to Regulatory Approval－
- 2024/07/01 News
Sanyo Chemical Industries, Ltd. and Professor Naoki Morimoto of the Department of Plastic and Reconstructive Surgery, Kyoto University Hospital, are pleased to announce positive results from a corporate clinical trial initiated in July 2021 for Silk-Elastin® Sponge, a novel healing material jointly developed for the treatment of chronic wounds*1. This collaborative R&D has led to the successful development of Silk-Elastin® Sponge, with clinical trials has been conducted since July 2021 to evaluate its efficacy and safety.
Based on the trial results, Sanyo Chemical has initiated the application for manufacturing and marketing approval of Silk-Elastin® Sponge for chronic wound healing, aiming for practical application within the next fiscal year.